Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. (Q51914262)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

adult attention deficit hyperactivity disorder

27 December 2019

main subject

1 reference

5

Stephen V Faraone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

2

Joseph Biederman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

4

Timothy E Wilens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Richard H Weisler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Thomas J Spencer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Allan K Chrisman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Stephanie C Read

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Simon J Tulloch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

625-639

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Hyperactives as young adults: a controlled prospective ten-year follow-up of 75 children

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Attention-deficit/hyperactivity disorder: perspectives from neuroimaging

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

A review of adult ADHD: a neuropsychological and neuroimaging perspective.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Attention-deficit/hyperactivity disorder in adults: an overview

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

AHA Scientific Statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Failed attempts at intranasal abuse of Concerta

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900013687

7 January 2021

10.1017/S1092852900013687

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16871129%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference